share_log

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024

Truist Securities Maintains Buy on Tenet Healthcare, Raises Price Target to $105-Report Released on 8th February 2024

Truist Securities维持对Tenet Healthcare的买入,将目标股价上调至105美元,于2024年2月8日发布的报告
Benzinga ·  02/09 17:02

Truist Securities analyst David Macdonald maintains Tenet Healthcare (NYSE:THC) with a Buy and raises the price target from $92 to $105.

Truist Securities分析师戴维·麦克唐纳维持Tenet Healthcare(纽约证券交易所代码:THC)的买入并将目标股价从92美元上调至105美元。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发